Data / Drug companies / Drugs for further processing
Companies that list drugs for further processing products: 495 companies and 5,636 products in the FDA NDC directory
The FDA National Drug Code Directory lists 5,636 products that are drugs for further processing from 495 companies. The ten largest listers hold 33.4% of them, and the newest started marketing on October 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 495
- Products
- 5,636
- Drugs by generic name
- 0
- Main marketing category
- Drugs for further processing
Companies with the most drugs for further processing
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Deseret Biologicals, Inc. | 397 | liquid | Drugs for further processing | October 29, 2026 |
| Aurobindo Pharma Limited | 384 | tablet, film coated; tablet | Drugs for further processing | January 10, 2024 |
| Catalent Pharma Solutions, LLC | 273 | capsule; tablet, film coated | Drugs for further processing | September 11, 2026 |
| Herbamed AG | 186 | liquid; powder | Drugs for further processing | October 7, 2026 |
| Aurobindo Pharma Limited | 138 | tablet; tablet, film coated | Drugs for further processing | July 15, 2026 |
| Patheon Softgels Inc. | 122 | capsule; capsule, liquid filled | Drugs for further processing | October 15, 2025 |
| Apotheca Company | 106 | liquid; powder | Drugs for further processing | March 26, 2026 |
| Patheon Italia S.p.A. | 99 | injection, powder, lyophilized, for solution; injection, solution | Drugs for further processing | September 4, 2026 |
| Patheon Manufacturing Services LLC | 90 | injection; tablet | Drugs for further processing | September 4, 2026 |
| Actavis Pharma, Inc. | 89 | tablet; capsule | Drugs for further processing | August 27, 2025 |
| Patheon Inc. | 77 | tablet, film coated; tablet | Drugs for further processing | July 22, 2026 |
| Patheon Inc. | 55 | tablet, film coated; tablet | Drugs for further processing | May 15, 2026 |
| Societal Cdmo Gainesville, LLC | 55 | capsule, extended release; tablet | Drugs for further processing | June 1, 2025 |
| Granules India Limited | 53 | powder; tablet | Drugs for further processing | December 26, 2025 |
| Lilly Del Caribe, Inc. | 50 | capsule; tablet, film coated | Drugs for further processing | November 25, 2025 |
| Isomedix Operations Inc | 47 | powder; implant | Drugs for further processing | October 22, 2026 |
| Pfizer Ireland Pharmaceuticals Unlimited Company | 46 | capsule; capsule, extended release | Drugs for further processing | April 3, 2026 |
| Patheon France S.a.s. | 44 | tablet, film coated; capsule | Drugs for further processing | May 11, 2026 |
| BSP Pharmaceuticals S.p.A. | 43 | injection, solution; injection, powder, lyophilized, for solution | Drugs for further processing | September 22, 2026 |
| Prodose, Inc. | 43 | capsule, liquid filled; tablet, film coated | Drugs for further processing | July 31, 2026 |
| Adare Pharmaceuticals Inc | 41 | capsule; capsule, extended release | Drugs for further processing | April 30, 2024 |
| Catalent Micron Technologies, Inc. | 41 | powder | Drugs for further processing | February 28, 2025 |
| Catalent Ontario Limited | 41 | capsule, liquid filled; capsule, gelatin coated | Drugs for further processing | May 29, 2026 |
| Elanco US Inc. | 41 | tablet, chewable; tablet | Drugs for further processing | October 7, 2024 |
| Patheon Pharmaceuticals Inc. | 41 | tablet, film coated; capsule | Drugs for further processing | July 13, 2026 |
| Teva Pharmaceuticals USA, Inc. | 40 | tablet, film coated; capsule | Drugs for further processing | May 13, 2026 |
| Spi Pharma, Inc. | 39 | powder; gel | Drugs for further processing | June 4, 2026 |
| Takeda Pharmaceutical Company Limited | 36 | tablet; injection, powder, lyophilized, for suspension | Drugs for further processing | May 20, 2014 |
| Pfizer Manufacturing Deutschland GmbH | 34 | tablet, film coated; capsule | Drugs for further processing | January 30, 2026 |
| AstraZeneca AB | 33 | tablet, film coated; tablet | Drugs for further processing | November 18, 2025 |
| Boehringer Ingelheim Pharma GmbH and Co. KG | 33 | tablet; powder | Drugs for further processing | October 7, 2025 |
| L. Perrigo Company | 33 | solution; tablet, coated | Drugs for further processing | October 19, 2016 |
| HK Kolmar Canada, Inc | 32 | lotion; gel | Drugs for further processing | December 15, 2021 |
| Allergan, Inc. | 31 | tablet; tablet, film coated | Drugs for further processing | January 30, 2017 |
| Eli Lilly and Company | 31 | injection, solution; injection, suspension | Drugs for further processing | June 15, 2020 |
| Hovione Farmaciencia SA | 30 | powder; capsule | Drugs for further processing | May 13, 2026 |
| Otsuka Pharmaceutical Co., LTD. | 30 | tablet; injection, powder, lyophilized, for suspension, extended release | Drugs for further processing | May 10, 2023 |
| Synergy Health Ast, LLC | 30 | implant; injection, powder, for suspension | Drugs for further processing | March 11, 2026 |
| Bayer HealthCare LLC. | 29 | capsule; capsule, liquid filled | Drugs for further processing | July 1, 2026 |
| AbbVie Inc. | 28 | tablet; injection, solution | Drugs for further processing | September 29, 2026 |
| TCB USA Corporation | 27 | tablet, coated; tablet | Drugs for further processing | September 12, 2023 |
| Pure Source, LLC | 26 | cream; liquid | Drugs for further processing | September 19, 2024 |
| Shield Pharmaceuticals Corp | 26 | capsule, liquid filled; tablet, film coated | Drugs for further processing | September 21, 2026 |
| Siegfried Hameln GmbH | 26 | injection, solution | Drugs for further processing | October 19, 2026 |
| Bamboo US Bidco LCC | 24 | injection, powder, lyophilized, for solution; injection, solution | Drugs for further processing | October 8, 2026 |
| Fertin Pharma A/s | 24 | gum, chewing; lozenge | Drugs for further processing | February 10, 2022 |
| Lonza Biologics, Inc. | 24 | liquid; suspension | Drugs for further processing | April 17, 2026 |
| Novo Nordisk Production Belgium SA | 24 | injection, solution; injection | Drugs for further processing | July 1, 2025 |
| Penn Pharmaceutical Services Limited | 24 | tablet, film coated; capsule | Drugs for further processing | March 22, 2024 |
| Takeda GmbH | 24 | tablet, film coated; tablet | Drugs for further processing | May 18, 2018 |
| Vovantis Laboratories Private Limited | 24 | granule; tablet, effervescent | Drugs for further processing | October 1, 2026 |
| Zoetis Inc. | 24 | tablet, chewable; tablet, coated | Drugs for further processing | May 1, 2026 |
| Glaxo Operations Uk Ltd | 23 | tablet, film coated; spray, metered | Drugs for further processing | March 17, 2026 |
| Laboratoire Schmidt-Nagel Inc. | 23 | powder | Drugs for further processing | January 19, 2026 |
| Miyoshi America, Inc. | 23 | powder; powder, for solution | Drugs for further processing | September 1, 2025 |
| AbbVie Ireland NL B.V. | 21 | tablet; tablet, film coated | Drugs for further processing | June 2, 2023 |
| Catalent U.k. Swindon Zydis Limited | 21 | tablet, orally disintegrating; tablet | Drugs for further processing | February 1, 2023 |
| Dr. Reddy's Laboratories Inc. | 21 | lozenge; tablet, extended release | Drugs for further processing | January 1, 2025 |
| Organon Pharma (uk) Limited | 21 | tablet, film coated; tablet | Drugs for further processing | October 16, 2006 |
| SpecGx LLC | 21 | powder; tablet | Drugs for further processing | December 19, 2022 |
| Actavis Pharma, Inc. | 20 | tablet, film coated; tablet | Drugs for further processing | February 14, 2025 |
| Eli Lilly Italia Spa | 20 | injection, solution; injection, suspension | Drugs for further processing | February 3, 2025 |
| Samsung Biologics Co., Ltd. | 20 | solution; injection, solution | Drugs for further processing | December 8, 2025 |
| Teva Pharmaceuticals, Inc. | 20 | capsule, extended release; tablet | Drugs for further processing | July 21, 2026 |
| Regeneron Pharmaceuticals, Inc. | 19 | injection, solution; solution | Drugs for further processing | August 18, 2023 |
| Sanofi Winthrop Industrie | 19 | tablet, film coated; capsule, extended release | Drugs for further processing | December 27, 2013 |
| Janssen Ortho LLC | 18 | tablet, film coated; tablet, film coated, extended release | Drugs for further processing | February 14, 2018 |
| Nestmann Pharma GmbH | 18 | liquid; tablet, orally disintegrating | Drugs for further processing | August 21, 2024 |
| Resilience US, LLC | 18 | injection, solution | Drugs for further processing | August 15, 2025 |
| Advanced Dispersed Particles SL. | 17 | powder | Drugs for further processing | March 22, 2024 |
| Ezuf NL B.V. | 17 | liquid; powder | Drugs for further processing | July 28, 2023 |
| Ricola Ag | 17 | lozenge | Drugs for further processing | March 1, 2026 |
| Rottendorf Pharma GmbH | 17 | tablet; tablet, film coated | Drugs for further processing | November 22, 2024 |
| Ucb Pharma S.A. | 17 | tablet, film coated; tablet, film coated, extended release | Drugs for further processing | May 12, 2016 |
| AstraZeneca Pharmaceuticals LP | 16 | tablet, film coated; tablet, film coated, extended release | Drugs for further processing | August 4, 2022 |
| Biogen Inc. | 16 | powder, for suspension; powder, for solution | Drugs for further processing | May 18, 2025 |
| Lonza AG | 16 | liquid; solution | Drugs for further processing | March 24, 2026 |
| Patheon Puerto Rico, Inc. | 16 | tablet; tablet, film coated | Drugs for further processing | January 1, 2025 |
| Bayer AG | 15 | tablet, film coated; tablet, coated | Drugs for further processing | November 19, 2025 |
| Bora Pharmaceutical Services Inc. | 15 | tablet, film coated; capsule, extended release | Drugs for further processing | November 7, 2022 |
| Catalent Germany Eberbach GmbH | 15 | capsule; capsule, liquid filled | Drugs for further processing | April 15, 2024 |
| Contract Pharmacal Corp. | 15 | tablet, film coated; tablet, chewable | Drugs for further processing | October 10, 2024 |
| Dr. Reddy's Laboratories Limited | 15 | tablet; tablet, extended release | Drugs for further processing | December 10, 2024 |
| L Perrigo Company | 15 | solution; lozenge | Drugs for further processing | September 2, 2025 |
| Opella Healthcare International Sas | 15 | tablet; tablet, film coated | Drugs for further processing | April 3, 2026 |
| Spi Pharma Inc. | 15 | gel; paste | Drugs for further processing | June 18, 2026 |
| Alkermes, Inc. | 14 | injection, suspension; injection, suspension, extended release | Drugs for further processing | May 28, 2021 |
| Bioventure Healthcare - Fze | 14 | capsule, liquid filled; capsule | Drugs for further processing | October 16, 2023 |
| Chugai Pharmaceutical Co., Ltd. | 14 | injection, solution; injection, solution, concentrate | Drugs for further processing | June 10, 2026 |
| Elementis SRL, Inc. | 14 | solution | Drugs for further processing | March 26, 2021 |
| Genentech, Inc. | 14 | liquid; solution | Drugs for further processing | May 16, 2023 |
| Nitro Quimica Corporation DBA Alchemix a Nitro Quimica Corporation | 14 | liquid; gel | Drugs for further processing | December 1, 2023 |
| Recordati Industria Chimica E Farmaceutica Spa | 14 | powder | Drugs for further processing | July 30, 2010 |
| Viatris Pharmaceuticals LLC | 14 | tablet, film coated; tablet, multilayer, extended release | Export only | October 28, 2025 |
| Apl Healthcare Limited | 13 | tablet; capsule | Drugs for further processing | October 8, 2021 |
| Asclemed USA, Inc. | 13 | powder; kit | Drugs for further processing | September 27, 2022 |
| Aurobindo Pharma Limited | 13 | tablet, film coated; granule | Drugs for further processing | September 28, 2026 |
| Corden Pharma GmbH | 13 | tablet; tablet, film coated | Drugs for further processing | October 2, 2025 |
| Sakai Chemical Industry Co.,Ltd. | 13 | powder | Drugs for further processing | July 1, 2026 |
| Taekyung SBC Co., LTD | 13 | powder | Drugs for further processing | December 1, 2025 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.